Clinical Trial Update: Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer

View source ↗

Summary

A clinical trial update examining genetic risk factors for osteonecrosis of the jaw in patients with metastatic cancer, including those exposed to bisphosphonat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bisphosphonate-related Osteonecrosis of the Jaw
• Cancer
• Osteonecrosis of the Jaw

Snippet

Sponsor: University of Michigan | Conditions: Bone Diseases, Metastases | Status: COMPLETED